ArticleJournal of stem cells & regenerative medicine2025
Exosomes derived from bone marrow mesenchymal stem cells attenuate OGD/R-induced apoptosis in PC-12 cells via activation of the PI3K/AKT pathway.
Article in Journal of stem cells & regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to investigate the role of exosomes derived from bone marrow mesenchymal stem cell (BMSC) with or without hypoxic precondition (HP) play in ischemic stroke, and the underlying mechanisms. Methods: Exosomes were characterized by transmission electron microscopy, western blot, and nanoparticle tracking analysis. To simulate neuronal ischemia-reperfusion injury, PC-12 cells underwent oxygen-glucose deprivation followed by reoxygenation (OGD/R). Cell viability and membrane integrity were assessed using CCK-8 and LDH assays, respectively. Apoptosis was evaluated by flow cytometry and TUNEL assay, while the expression of apoptosis-related proteins was analyzed via western blot. Results: Exosomes derived from BMSC activated the PI3K/Akt signaling pathway and subsequently suppressed apoptosis, thereby ameliorating cellular injury induced by OGD/R. HP enhanced exosome secretion from BMSC; however, it did not significantly alter the particle size distribution of the released exosomes. Notably, when administered at the same concentration, no substantial difference in therapeutic efficacy was observed between exosomes derived from normoxic BMSC and those from HP-treated BMSC. The anti-apoptotic effects conferred by these exosomes were effectively abolished upon treatment with the PI3K inhibitor LY294002, indicating a PI3K/Akt-dependent mechanism. Conclusions: Exosomes derived frvom BMSC effectively inhibitedp aupoptposis induced by OpGD/R through uactivation of the PI3K/Akt. Although HP significantly enhanced the secretion of exosomes from BMSC, it did not improve the therapeutic efficacy of these exosomes when administered at an equivalent dosage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.